Menu

Life Sciences

Insightful, customized solutions for innovative business leaders

In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising and managing capital to protecting intellectual property and prioritizing research and development efforts, you require business advisors who understand your complex issues and the specific business problems you might face.

Featured Insights

CBI's 14th Life Sciences Accounting & Reporting Congress

EVENT

CBI's 14th Life Sciences Accounting & Reporting Congress

Join RSM at CBI's 14th Life Sciences Accounting & Reporting Congress on March 19-21, 2018 in Philadelphia, PA.

Life sciences 2017 tax year in review—And a look ahead

INSIGHT ARTICLE

Life sciences 2017 tax year in review—And a look ahead

Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2018.

Life sciences companies: Revenue recognition is changing

INSIGHT ARTICLE

Life sciences companies: Revenue recognition is changing

Learn about key areas life sciences companies should address and steps they should take to implement the new revenue recognition guidance.

Third parties, 3 risks and your life sciences business

INSIGHT ARTICLE

Third parties, 3 risks and your life sciences business

Third parties provide a vital business partnership for growing life sciences companies, but there are risks to consider.

ARTICLE

Bribery and corruption in the life sciences sector

This recent interview with Risk & Compliance magazine discusses the unique bribery and corruption risks life sciences organizations face.

EU value added tax refund potential for pharmaceutical companies

TAX BLOG

EU value added tax refund potential for pharmaceutical companies

A recent opinion by the Advocate General (AG) for the European Court of Justice (ECJ) opens the door for pharmaceutical companies to potentially claw back previously charged value added tax (VAT).

Life Sciences Insights

( * = Required fields)

Contact Our Team

John Lanza  LinkedIn
National Life Sciences Practice Leader

800.274.3978
John.Lanza@rsmus.com



EVENTS / WEBCASTS

ON DEMAND WEBCAST

Revenue recognition: Key considerations for the life sciences industry

Join RSM on Dec. 13 as we share our insights on how the new revenue recognition standard (ASC 606) affects the life sciences industry.

  • December 13, 2017

IN-PERSON EVENT

Health care and life sciences private equity and finance conference

RSM and McGuire Woods present the 15th annual health care and life sciences private equity conference for deal professionals.

  • February 21, 2018